Loading...
Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
Postoperative patients have risk recurring, even for completed resected early stage non-small-cell lung cancer (NSCLC). To control the recurrence rate, neoadjuvant and adjuvant therapies have been applied widely in clinical practice; however, neoadjuvant and adjuvant immunotherapy clinical trials on...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735538/ https://ncbi.nlm.nih.gov/pubmed/31564915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S218321 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|